Search Results - "Locker, G J"

Fulvestrant (‘Faslodex’) in pre-treated patients with advanced breast cancer: A single-centre experience by Steger, G.G., Bartsch, R., Wenzel, C., Pluschnig, U., Hussian, D., Sevelda, U., Locker, G.J., Gnant, M.F., Jakesz, R., Zielinski, C.C.

“…Fulvestrant (‘Faslodex’) is a new oestrogen receptor (ER) antagonist with no agonist effects. This report describes the experience of a single centre including…”
Get full text

The use of drotrecogin alfa in severe falciparum malaria by ROBAK, O, BOJIC, A, LOCKER, G. J, LACZIKA, K, RAMHARTER, M, STAUDINGER, T

“…We report the case of a 55-year-old male European who became septic after he returned from a four-week holiday to Uganda. Soon after; he was diagnosed with…”
Get full text

Use of abciximab-modified thrombelastography in patients undergoing cardiac surgery by KETTNER, S. C, PANZER, O. P, KOZEK, S. A, SEIBT, F. A, STOISER, B, KOFLER, J, LOCKER, G. J, ZIMPFER, M

“…Thrombelastography (TEG) is a reliable coagulation monitoring system that can guide blood product transfusion in cardiac surgery. The maximum amplitude (MA) of…”
Get full text

Continuous infusion versus intermittent administration of meropenem in critically ill patients by THALHAMMER, F, TRAUNMÜLLER, F, EL MENYAWI, I, FRASS, M, HOLLENSTEIN, U. M, LOCKER, G. J, STOISER, B, STAUDINGER, T, THALHAMMER-SCHERRER, R, BURGMANN, H

“…This prospective crossover study compared the pharmacokinetics of meropenem by continuous infusion and by intermittent administration in critically ill…”
Get full text

Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients by STAUDINGER, T, FRASS, M, RINTELEN, C, QUEHENBERGER, P, WAGNER, O, STOISER, B, LOCKER, G. J, LACZIKA, K, KNAPP, S, WATZKE, H

“…To evaluate thrombogenicity of prothrombin complex concentrates (PCCs) in critically ill patients. Prospective clinical study. Medical intensive care unit at a…”
Get full text

Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma by Schmidinger, M, Wenzel, C, Locker, G J, Muehlbacher, F, Steininger, R, Gnant, M, Crevenna, R, Budinsky, A C

“…We performed a pilot-study on pegylated liposomal doxorubicin (PLD) for advanced hepatocellular carcinoma. Seventeen patients received 40 mg/m(2) PLD…”
Get full text

Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shock by STAUDINGER, T, PRESTERL, E, KORDOVA, H, FRASS, M, GRANINGER, W, LOCKER, G. J, KNAPP, S, LACZIKA, K, KLAPPACHER, G, STOISER, B, WAGNER, A, TESINSKY, P

“…To evaluate the influence of pentoxifylline (PTX), a phosphodiesterase inhibitor, on cytokines and inflammatory proteins in patients suffering from septic…”
Get full text

Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosage by Meyer, B, Traunmüller, F, Hamwi, A, Hollenstein, U M, Locker, G J, Sperr, W R, Staudinger, T, Thalhammer-Scherrer, R, Burgmann, H, Thalhammer, F

“…Continuous venovenous hemofiltration (CVVH) is widely used in the management of critically ill patients, but only few administration guidelines for…”
Get full text

Comparison of oxygen cost of breathing with pressure-support ventilation and biphasic intermittent positive airway pressure ventilation by Staudinger, Thomas, Kordova, Hana, Roggla, Martin, Tesinsky, Pavel, Locker, Gottfried J, Laczika, Klaus, Knapp, Sylvia, Frass, Michael

“…OBJECTIVETo assess the oxygen cost of breathing with either pressure-support ventilation (PSV) or biphasic intermittent positive airway pressure ventilation…”
Get full text

Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer by Schmidinger, M, Budinsky, A C, Wenzel, C, Piribauer, M, Brix, R, Kautzky, M, Oder, W, Locker, G J, Zielinski, C C, Steger, G G

“…Glutathione has been shown to be an effective chemoprotector against cisplatin-induced side effects in patients with ovarian cancer. In view of this fact, we…”
Get more information

Homocysteine and laminin are not prognostic markers in patients with septic inflammatory response syndrome by Stoiser, B, Thalhammer, F, El-Menyawi, I, Wilfing, A, Daxböck, F, Locker, G J, Burgmann, H

“…The aim of this study was to measure plasma homocysteine and laminin concentrations in patients with nonbacteremic systemic inflammatory response syndrome…”
Get full text

Activation of endothelium by immunotherapy with interleukin‐2 in patients with malignant disorders by Locker, Gottfried J., Kapiotis, Stylianos, Veitl, Marvio, Mader, Robert M., Stoiser, Brigitte, Kofler, Julia, Sieder, Anna E., Rainer, Hugo, Steger, Günther G., Mannhalter, Christine, Wagner, Oswald F.

“…Treatment with intravenous recombinant human interleukin‐2 (rh IL‐2) is frequently accompanied by the capillary leak syndrome and disturbances of the…”
Get full text

Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit by Staudinger, Thomas, Stoiser, Brigitte, Müllner, Marcus, Locker, Gottfried J, Laczika, Klaus, Knapp, Sylvia, Burgmann, Heinz, Wilfing, Astrid, Kofler, Julia, Thalhammer, Florian, Frass, Michael

“…OBJECTIVE:To assess survival in cancer patients admitted to an intensive care unit (ICU) with respect to the nature of malignancy, cause of ICU admittance, and…”
Get full text

Bronchoscopy via a redesigned Combitube in the esophageal position : A clinical evaluation by KRAFFT, P, RÖGGLA, M, FRIDRICH, P, LOCKER, G. J, FRASS, M, BENUMOF, J. L

“…The esophageal-tracheal Combitube (Kendall-Sheridan Catheter Corp., Argyle, NY) is an effective device for providing adequate gas exchange. However, tracheal…”
Get full text

Sequential administration of interferon γ and interleukin-2 in metastatic renal cell carcinoma : results of a phase II trial by SCHMIDINGER, M, STEGER, G. G, WENZEL, C, LOCKER, G. J, BRODOWICZ, T, BUDINSKY, A. C, WILTSCHKE, C, KRAMER, G, MARBERGER, M, ZIELINSKI, C. C

“…Because of the known efficacy of several cytokines in the treatment of advanced renal cell cancer (RCC), we have conducted a phase II trial of the efficacy and…”
Get full text

Long-term use of an endovascular temperature catheter by Krizanac, D, Bojic, A, Rabitsch, W, Schellongowski, P, Locker, G J, Laczika, K, Staudinger, T

“…A patient suffering from severe cutaneous graft versus host disease (GvHD) developed generalized epidermolysis and refractory hypothermia. Due to the…”
Get full text

Placement of a pulmonary artery catheter via a previously unrecognized persistent left superior vena cava by Stoiser, B, Vorbeck, F, Kofler, J, Locker, G J, Burgmann, H

“…This case report describes a patient with persistent left superior vena cava (LSVC) as discovered by difficult placement of a pulmonary artery catheter via the…”
Get more information

Docetaxel monotherapy in heavily pretreated metastatic breast cancer : a multicenter, community-based feasibility trial by SCHMIDINGER, Manuela, BUDINSKY, Alexandra C, SEEWANN, Lothar, HOJAS, Sabine, BLACH, Michaela, ZIELINSKI, Christoph C, STEGER, Guenther G, WENZEL, Catharina, LOCKER, Gottfried J, PLUSCHNIG, Ursula, BRODOWICZ, Thomas, KUBISTA, Ernst, MACA, Sylvia, ZABERNIGG, August, ILSINGER, Peter

“…To evaluate the efficacy and safety of docetaxel in heavily pretreated and anthracycline-resistant patients with metastatic breast cancer in an outpatient…”
Get full text

Decrease of Circulating Hematopoietic Progenitor Cells During Interleukin-2 Treatment is Associated with an Increase of Vascular Cell Adhesion Molecule-1, a Critical Molecule for Progenitor Cell Adhesion by Locker, Gottfried J., Stoiser, Brigitte, Losert, Heidrun, Wenzel, Catharina, Öhler, Leopold, Kabrna, Eva, Geissler, Klaus

“…Administration of interleukin-2 (IL-2) to cancer patients has been shown to transiently decrease the number of circulating hematopoietic progenitor cells, but…”
Get full text

Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2 by Locker, G J, Kofler, J, Stoiser, B, Wilfing, A, Wenzel, C, Wögerbauer, M, Steger, G G, Zielinski, C C, Mader, R, Burgmann, H

“…Immunotherapy with intravenous recombinant human interleukin-2 (rh IL-2) may be accompanied by hypotension and the emergence of capillary leak syndrome. Nitric…”
Get more information